Quanterix Stock
Quanterix Corporation
Company data
- Sector
- Healthcare
- Industry
- Medical - Devices
- Country
- United States
- CEO
- Everett V. Cunningham
- Employees
- 450
- Market cap
- $136 M
- IPO
- 07/12/2017
Quanterix Corporation, based in Billerica, Massachusetts, is a life sciences enterprise dedicated to pioneering and commercializing advanced digital immunoassay platforms. These sophisticated systems are designed to enhance precision health in both scientific research and diagnostic applications, reaching markets…
Quanterix stock: price history
1D
-6.5%
1W
-12.5%
1M
-1.4%
6M
-18.0%
YTD
-54.9%
1Y
-51.8%
2Y
-77.6%
5Y
-94.4%
10Y
–
Next earnings date
Next earnings date
09/11/2026 (in 23 days)
Volatility around earnings
~126% stronger price swings than usual
Ask the agents about Quanterix
Analyst assessment of Quanterix
PRICE TARGET LOW
US$3.00
CONSENSUS
US$3.00
MEDIAN
US$3.00
PRICE TARGET HIGH
US$3.00
0
STRONG BUY
5
BUY
5
HOLD
0
SELL
0
STRONG SELL
10
TOTAL · Buy
As of: 13/10/2026
Quanterix stock metrics
P/E
-1.09
P/B
0.57
EV/EBITDA
-1.27
RETURN ON EQUITY
-20.6%
NET MARGIN
-148.7%
DEBT/EQUITY
0.14
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
80.3%
FLOAT SHARES
37,985,790
AVG. DAILY VOLUME (30D)
790,941
Insider transactions (SEC)
Miller Michael Francis
Miller Michael Francis
Miller Michael Francis
Miller Michael Francis
Miller Michael Francis
Institutional holders
Comparable stocks
Frequently asked questions about Quanterix stock
What does Quanterix do?
Quanterix Corporation is a company in the Healthcare sector, Medical - Devices industry, headquartered in United States.
The CEO is Everett V. Cunningham, the company employs around 450 people.
The IPO was on 07/12/2017; the stock trades on NASDAQ under the ticker QTRX.
What do analysts say about Quanterix stock?
10 analysts rate the stock, the consensus is Buy (as of 13/10/2026).
The average price target is US$3.00, ranging from US$3.00 to US$3.00, with a median of US$3.00.
This is an external assessment, not a statement by Market Jury.
When does Quanterix report next?
The next earnings date is 09/11/2026.
Around past earnings, price swings were roughly 126% stronger than usual.
Does Quanterix pay a dividend?
No, Quanterix currently does not pay a dividend.
Which stocks are comparable to Quanterix?
Comparable stocks include Abbott Laboratories, Stryker, Boston Scientific, Edwards Lifesciences, DexCom, GE HealthCare Technologies, Zimmer Biomet Holdings and Align Technology.
How can I get Quanterix stock analyzed?
Clicking "Analyze stock" lets five strategies assess Quanterix against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.